News Mylan and Biocon file Herceptin biosimilar in Europe First Herceptin biosimilar filed in EU, companies say.
News Eleven seals deal with Roche on eye drug pipeline Deal helps biotech to move on from phase 3 failures
News England's new-look Cancer Drugs Fund begins But concerns remain about access to oncology medicines.
US FDA fast-tracks review of Roche's potential MS blockbuster Regulator to make decision by year end.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.